Answers are grounded in this paper and cite their sources.
Our pan-tumor study provides biological insights into the genetic heterogeneity and tissue specificities of multi-PIK3CA mutations, with potential clinical utility to guide PI3K inhibition strategies.
No takes yet. Share an insight, caveat, or question.
Sivakumar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: